Hage Raymond Joseph 4
4 · NOVAVAX INC · Filed Jul 6, 2009
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Hage Raymond Joseph
Sr. VP. Commercial Operations
Transactions
- Sale
Common Stock
2009-07-02$2.88/sh−1,392$4,009→ 171,434 total - Sale
Common Stock
2009-07-02$2.86/sh−1,500$4,290→ 169,934 total - Sale
Common Stock
2009-07-02$2.80/sh−10,300$28,840→ 92,734 total - Sale
Common Stock
2009-07-02$2.79/sh−19,200$53,568→ 73,534 total - Sale
Common Stock
2009-07-01$3.07/sh−1,061$3,257→ 10,451 total - Sale
Common Stock
2009-07-02$2.84/sh−2,000$5,680→ 138,200 total - Sale
Common Stock
2009-07-02$2.81/sh−30,030$84,384→ 103,034 total - Sale
Common Stock
2009-07-02$2.80/sh−24,138$67,586→ 11,512 total - Exercise/Conversion
Stock Option Right to Buy
2009-07-02+100,000→ 0 totalExercise: $0.74From: 2008-08-10Exp: 2015-08-10→ Common Stock (100,000 underlying) - Sale
Common Stock
2009-07-02$2.89/sh−708$2,046→ 172,826 total - Sale
Common Stock
2009-07-01$3.08/sh−5,200$16,016→ 5,251 total - Exercise/Conversion
Common Stock
2009-07-02$0.74/sh+100,000$74,000→ 173,534 total - Sale
Common Stock
2009-07-02$3.05/sh−37,884$115,546→ 35,650 total - Sale
Common Stock
2009-07-02$2.85/sh−29,734$84,742→ 140,200 total - Sale
Common Stock
2009-07-02$2.82/sh−5,136$14,484→ 133,064 total